Compare $MDXG vs $OLMA | Chartloom

Compare

$MDXG vs $OLMA

MiMedx Group Inc · Olema Pharmaceuticals Inc

MDXG

MiMedx Group Inc

OLMA

Olema Pharmaceuticals Inc

Compare $MDXG vs $OLMA

Comparing MiMedx Group Inc and Olema Pharmaceuticals Inc

MDXGMiMedx Group Inc

OLMAOlema Pharmaceuticals Inc

MDXGMiMedx Group Inc

Market cap

$681M

P/E (TTM)

110.63x

Forward P/E (NTM)

130.81x

Forward P/S (NTM)

2.16x

Rev growth (TTM)

-2.4%

YTD performance

-27.9%

52W performance

-34.2%

FCF yield

6.5%

OLMAOlema Pharmaceuticals Inc

Market cap

$683M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-27.1%

FCF yield

-24.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MDXG

OLMA

Detailed metrics comparison

MDXG

MiMedx Group Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

MDXG$681M

OLMA$683M

Enterprise Value

MDXG$562M

OLMA$637M

Price

MDXG$4.67

OLMA$7.82

P/E Ratio

MDXG110.63x

OLMAN/A

P/S Ratio

MDXG1.92x

OLMA0.00x

EV/Sales

MDXG1.58x

OLMA0.00x

EV/EBITDA

MDXG27.54x

OLMA0.00x

P/B Ratio

MDXG3.10x

OLMA1.67x

P/FCF Ratio

MDXG15.32x

OLMAN/A

EV/FCF

MDXG12.65x

OLMA-3.86x

PEG Ratio

MDXGN/A

OLMAN/A

Forward P/E (NTM)

MDXG130.81x

OLMAN/A

Forward P/S (NTM)

MDXG2.16x

OLMAN/A

Revenue (TTM)

MDXG$355M

OLMA$0

Revenue Growth (YoY)

MDXG-2.4%

OLMAN/A

Forward Rev Growth

MDXG22.1%

OLMA820.6%

Gross Margin (TTM)

MDXG78.8%

OLMA0.0%

Operating Margin (TTM)

MDXG2.5%

OLMA0.0%

EBITDA Margin (TTM)

MDXG5.7%

OLMA0.0%

Net Margin (TTM)

MDXG1.8%

OLMA0.0%

FCF Margin (TTM)

MDXG12.5%

OLMAN/A

Net Income (TTM)

MDXG$6M

OLMA$-205M

FCF (TTM)

MDXG$44M

OLMA$-165M

EPS (TTM)

MDXG$0.04

OLMA-$1.96

ROE (TTM)

MDXG2.6%

OLMA-4822.0%

ROA (TTM)

MDXG2.0%

OLMA-4300.0%

ROIC (TTM)

MDXG2.4%

OLMA-4788.0%

Cash

MDXG$136M

OLMA$49M

Debt

MDXG$17M

OLMA$3M

Net Cash/Debt

MDXG$119M

OLMA$46M

Current Ratio (TTM)

MDXG5.33x

OLMA8.86x

Quick Ratio (TTM)

MDXG4.79x

OLMA8.75x

Debt/Equity (TTM)

MDXG0.08x

OLMA0.01x

Debt/Assets (TTM)

MDXG0.0%

OLMA0.0%

Interest Coverage (TTM)

MDXGN/A

OLMAN/A

Net Debt/EBITDA (TTM)

MDXG0.00x

OLMA0.00x

Beta

MDXG1.20

OLMA1.98

52W Performance

MDXG-34.2%

OLMA-27.1%

YTD Performance

MDXG-27.9%

OLMA-69.1%

% from 52W High

MDXG-41.4%

OLMA-78.4%

% from 52W Low

MDXG54.1%

OLMA17.6%

Asset Turnover (TTM)

MDXG1.14x

OLMA0.00x

FCF Yield (TTM)

MDXG6.5%

OLMA-24.1%

Earnings Yield (TTM)

MDXG0.9%

OLMA-29.9%

Dividend Yield (TTM)

MDXGN/A

OLMAN/A

Rule of 40

MDXG10.1

OLMA0.0

EV/GP/RG

MDXG0.09

OLMAN/A

Ticker research

View MDXG research View OLMA research

Metric	MDXG MiMedx Group Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$681M	$683M
Enterprise Value	$562M	$637M
Price	$4.67	$7.82
P/E Ratio	110.63x	N/A
P/S Ratio	1.92x	0.00x
EV/Sales	1.58x	0.00x
EV/EBITDA	27.54x	0.00x
P/B Ratio	3.10x	1.67x
P/FCF Ratio	15.32x	N/A
EV/FCF	12.65x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	130.81x	N/A
Forward P/S (NTM)	2.16x	N/A
Revenue & Growth
Revenue (TTM)	$355M	$0
Revenue Growth (YoY)	-2.4%	N/A
Forward Rev Growth	22.1%	820.6%
Profitability
Gross Margin (TTM)	78.8%	0.0%
Operating Margin (TTM)	2.5%	0.0%
EBITDA Margin (TTM)	5.7%	0.0%
Net Margin (TTM)	1.8%	0.0%
FCF Margin (TTM)	12.5%	N/A
Net Income (TTM)	$6M	$-205M
FCF (TTM)	$44M	$-165M
EPS (TTM)	$0.04	-$1.96
ROE (TTM)	2.6%	-4822.0%
ROA (TTM)	2.0%	-4300.0%
ROIC (TTM)	2.4%	-4788.0%
Financial Health
Cash	$136M	$49M
Debt	$17M	$3M
Net Cash/Debt	$119M	$46M
Current Ratio (TTM)	5.33x	8.86x
Quick Ratio (TTM)	4.79x	8.75x
Debt/Equity (TTM)	0.08x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	1.98
52W Performance	-34.2%	-27.1%
YTD Performance	-27.9%	-69.1%
% from 52W High	-41.4%	-78.4%
% from 52W Low	54.1%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.00x
FCF Yield (TTM)	6.5%	-24.1%
Earnings Yield (TTM)	0.9%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	10.1	0.0
EV/GP/RG	0.09	N/A
Ticker research	View MDXG research	View OLMA research

Valuation

P/E Ratio

MDXG

110.63x

P/S Ratio

OLMA

0.00x

MDXG

1.92x

EV/FCF

OLMA

-3.86x

MDXG

12.65x

Growth & revenue

Revenue Growth TTM

MDXG

-2.4%

Forward Revenue Growth

OLMA

820.6%

MDXG

22.1%

Profitability & performance

Gross Margin

MDXG

78.8%

OLMA

0.0%

ROE

MDXG

2.6%

OLMA

-4822.0%

FCF Yield %

MDXG

6.5%

OLMA

-24.1%

52-Week Performance

OLMA

-27.1%

MDXG

-34.2%

Detailed metrics comparison

MDXG

MiMedx Group Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

MDXG$681M

OLMA$683M

Enterprise Value

MDXG$562M

OLMA$637M

Price

MDXG$4.67

OLMA$7.82

P/E Ratio

MDXG110.63x

OLMAN/A

P/S Ratio

MDXG1.92x

OLMA0.00x

EV/Sales

MDXG1.58x

OLMA0.00x

EV/EBITDA

MDXG27.54x

OLMA0.00x

P/B Ratio

MDXG3.10x

OLMA1.67x

P/FCF Ratio

MDXG15.32x

OLMAN/A

EV/FCF

MDXG12.65x

OLMA-3.86x

PEG Ratio

MDXGN/A

OLMAN/A

Forward P/E (NTM)

MDXG130.81x

OLMAN/A

Forward P/S (NTM)

MDXG2.16x

OLMAN/A

Revenue (TTM)

MDXG$355M

OLMA$0

Revenue Growth (YoY)

MDXG-2.4%

OLMAN/A

Forward Rev Growth

MDXG22.1%

OLMA820.6%

Gross Margin (TTM)

MDXG78.8%

OLMA0.0%

Operating Margin (TTM)

MDXG2.5%

OLMA0.0%

EBITDA Margin (TTM)

MDXG5.7%

OLMA0.0%

Net Margin (TTM)

MDXG1.8%

OLMA0.0%

FCF Margin (TTM)

MDXG12.5%

OLMAN/A

Net Income (TTM)

MDXG$6M

OLMA$-205M

FCF (TTM)

MDXG$44M

OLMA$-165M

EPS (TTM)

MDXG$0.04

OLMA-$1.96

ROE (TTM)

MDXG2.6%

OLMA-4822.0%

ROA (TTM)

MDXG2.0%

OLMA-4300.0%

ROIC (TTM)

MDXG2.4%

OLMA-4788.0%

Cash

MDXG$136M

OLMA$49M

Debt

MDXG$17M

OLMA$3M

Net Cash/Debt

MDXG$119M

OLMA$46M

Current Ratio (TTM)

MDXG5.33x

OLMA8.86x

Quick Ratio (TTM)

MDXG4.79x

OLMA8.75x

Debt/Equity (TTM)

MDXG0.08x

OLMA0.01x

Debt/Assets (TTM)

MDXG0.0%

OLMA0.0%

Interest Coverage (TTM)

MDXGN/A

OLMAN/A

Net Debt/EBITDA (TTM)

MDXG0.00x

OLMA0.00x

Beta

MDXG1.20

OLMA1.98

52W Performance

MDXG-34.2%

OLMA-27.1%

YTD Performance

MDXG-27.9%

OLMA-69.1%

% from 52W High

MDXG-41.4%

OLMA-78.4%

% from 52W Low

MDXG54.1%

OLMA17.6%

Asset Turnover (TTM)

MDXG1.14x

OLMA0.00x

FCF Yield (TTM)

MDXG6.5%

OLMA-24.1%

Earnings Yield (TTM)

MDXG0.9%

OLMA-29.9%

Dividend Yield (TTM)

MDXGN/A

OLMAN/A

Rule of 40

MDXG10.1

OLMA0.0

EV/GP/RG

MDXG0.09

OLMAN/A

Ticker research

View MDXG research View OLMA research

Metric	MDXG MiMedx Group Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$681M	$683M
Enterprise Value	$562M	$637M
Price	$4.67	$7.82
P/E Ratio	110.63x	N/A
P/S Ratio	1.92x	0.00x
EV/Sales	1.58x	0.00x
EV/EBITDA	27.54x	0.00x
P/B Ratio	3.10x	1.67x
P/FCF Ratio	15.32x	N/A
EV/FCF	12.65x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	130.81x	N/A
Forward P/S (NTM)	2.16x	N/A
Revenue & Growth
Revenue (TTM)	$355M	$0
Revenue Growth (YoY)	-2.4%	N/A
Forward Rev Growth	22.1%	820.6%
Profitability
Gross Margin (TTM)	78.8%	0.0%
Operating Margin (TTM)	2.5%	0.0%
EBITDA Margin (TTM)	5.7%	0.0%
Net Margin (TTM)	1.8%	0.0%
FCF Margin (TTM)	12.5%	N/A
Net Income (TTM)	$6M	$-205M
FCF (TTM)	$44M	$-165M
EPS (TTM)	$0.04	-$1.96
ROE (TTM)	2.6%	-4822.0%
ROA (TTM)	2.0%	-4300.0%
ROIC (TTM)	2.4%	-4788.0%
Financial Health
Cash	$136M	$49M
Debt	$17M	$3M
Net Cash/Debt	$119M	$46M
Current Ratio (TTM)	5.33x	8.86x
Quick Ratio (TTM)	4.79x	8.75x
Debt/Equity (TTM)	0.08x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	1.98
52W Performance	-34.2%	-27.1%
YTD Performance	-27.9%	-69.1%
% from 52W High	-41.4%	-78.4%
% from 52W Low	54.1%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	1.14x	0.00x
FCF Yield (TTM)	6.5%	-24.1%
Earnings Yield (TTM)	0.9%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	10.1	0.0
EV/GP/RG	0.09	N/A
Ticker research	View MDXG research	View OLMA research